Lay the Groundwork: Analyzing the Data Supporting ADCs in Metastatic Breast Cancer

Breast cancer (BC) is the leading cause of cancer mortality in women. Although more than 80% of BC cases are early stage at diagnosis, approximately 5% present with incurable mBC. Even after completion of curative-intent treatment, 15–25% of patients ultimately develop mBC, which only has a low 5-year survival rate of only ~30%. Join Dr. Joyce O’Shaughnessy as she examines the efficacy and safety data that support the use of antibody-drug conjugates, or ADCs, in the management of mBC on this Monday Morning Joe Episode.

Bookmark this page and check back for new episodes!
   • Monday Morning Joe in mBC  

Episode 1: The ABCs of Antibody-Drug Conjugates (ADCs): The Basics About ADCs for the Treatment of Metastatic Breast Cancer (mBC)

Episode 2: Lay the Groundwork: Analyzing the Data Supporting Antibody-Drug Conjugates (ADCs) in Metastatic Breast Cancer (mBC)

Episode 3: Look Before You Leap: Prevention and Mitigation of Treatment-Emergent Adverse Events (TEAEs)

Episode 4: Hot Off the Presses: The Most Recent Data on Antibody-Drug Conjugates (ADCs) for the Treatment of Metastatic Breast Cancer (mBC)

ExchangeCME.com is an online community of more than 60,000 active healthcare professionals who have access to a variety of enduring educational activities and other disease state–focused resources. The Website’s core mission is to support patient-centered care via education that is tailored to the needs of various clinician audiences.

By consolidating evidence-based resources and hosting only accredited educational programs without any promotional content or advertising, ExchangeCME.com serves as an independent, trusted, and balanced source of free CME/CE for physicians, nurses, pharmacists, and other healthcare providers.

Follow us on socials!
  / exchangecme  
  / exchangecme  
  / 10863550  

#breastcancer
#breastcancerawareness
#breastcancertreatment
#breastcancerawarenessmonth
#breastcancerpatient

Standard License and Enhance License Music Track ID 498181 – Monetization ID 9U2PR4M3SXKWCJMT